|
1191
|
Invaplex 50
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Subunit
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1, Phase 2
|
Intranasal
|
34258576
|
NCT00485134
|
|
1203
|
InvaplexAR
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Recombinant
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1
|
Intranasal
|
NA
|
NCT02445963
|
|
1238
|
TB/FLU-01L
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Viral vector
|
Research Institute for Biological Safety Problems
|
Clinical - Phase 1
|
Intranasal
|
NA
|
NCT03017378
|
|
1367
|
BW-1010
|
Anthrax
|
Bacillus anthracis
|
Recombinant
|
Blue Willow Biologics
|
Clinical - Phase 1
|
Intranasal
|
NA
|
NCT04148118
|